HTW heartware limited

htw who, page-2

  1. 3,291 Posts.
    lightbulb Created with Sketch. 76
    HTW WHO???????????????

    In 2006, Thoratec generated revenue of US$105 million from LVAD
    sales. With destination therapy use, the market may potentially
    increase to over US$500 million in coming years. Both Throratec
    and Ventracor are very well placed, being the two clear leaders in
    this market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.